Q-omics provides the consensus-scored RPL23AP22 profile across patient tissues and cancer cell-line models. RPL23AP22 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in KICH. Additionally, RPL23AP22 RNA expression shows 5,262 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KICH, and STAD as cancer lineages where RPL23AP22 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.